BENDAMUSTINE PLUS RITUXIMAB IN 65 YEAR AND ABOVE UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

被引：0
|
作者：
De La Fuente, A. [1 ]
Beneit, P. [2 ]
Gutierrez, A. [3 ]
Callejas, M. [4 ]
Garcia Marco, J. A. [5 ]
Garcia Malo, M. D. [6 ]
de la Serna, J. [7 ]
Gonzalez Gascon y Marin, I. [8 ]
Garcia Sanchis, L. [9 ]
Ballesteros, M. [10 ]
Jarque, I. [11 ]
Ochoa Grullon, J. [12 ]
Iglesias, R.
Estevez, M. [1 ]
de Ona, R. [1 ]
Prieto, E. [13 ]
Diaz-Lopez, A. [14 ]
Baltasar, P. [15 ]
机构：
[1] MD Anderson CC Madrid Spain, Hematol, Madrid, Spain
[2] H San Juan, Hematol, Alicante, Spain
[3] HU Son Espases, Hematol, Palma De Mallorca, Spain
[4] HU Principe Asturias, Hematol, Alcala De Henares, Spain
[5] HU Puerta Hierro Majadahonda, Hematol, Madrid, Spain
[6] HGU Morales Meseguer, Hematol, Murcia, Spain
[7] HU 12 Octubre, Hematol, Madrid, Spain
[8] H Infanta Leonor, Hematol, Madrid, Spain
[9] H Gen Castellon, Hematol, Castellon de La Plana, Spain
[10] GU Gregorio Maranon, Hematol, Madrid, Spain
[11] HU La Fe, Hematol, Valencia, Spain
[12] H Clin San Carlos, Inmunol, Madrid, Spain
[13] Hosp Fdn Jimenez Diaz, Hematol, Madrid, Spain
[14] Fdn MD Anderson, Traslat Med, Madrid, Spain
[15] HU La Paz, Hematol, Madrid, Spain
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1082
引用
收藏
页码：445 / 445
页数：1
相关论文
共 50 条
  • [41] BRUIN CLL-313: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Trial in Progress)
    Levy, Alex
    Jurczak, Wojciech
    Dartigeas, Caroline
    Coscia, Marta
    Ganly, Peter S.
    Al-Jazayrly, Ghassan
    Wang, Chunxiao
    Bao, Katherine
    Leow, Ching Ching
    Shahda, Safi
    Zinzani, Pier Luigi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S269 - S269
  • [42] Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia
    Knauf, Wolfgang U.
    Lissichkov, Toshko
    Aldaoud, Ali
    Liberati, Anna
    Loscertales, Javier
    Herbrecht, Raoul
    Juliusson, Gunnar
    Postner, Gerhard
    Gercheva, Liana
    Goranov, Stefan
    Becker, Martin
    Fricke, Hans-Joerg
    Huguet, Francoise
    Del Giudice, Ilaria
    Klein, Peter
    Tremmel, Lothar
    Merkle, Karlheinz
    Montillo, Marco
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4378 - 4384
  • [43] Results of a phase II multicenter study of obinutuzumab plus bendamustine in pts with previously untreated chronic lymphocytic leukemia (CLL).
    Sharman, Jeff Porter
    Yimer, Habte Aragaw
    Boxer, Michael
    DiBella, Nicholas
    Babu, Sunil
    Li, Jia
    Mun, . . . Yong Jun
    Skettino, Sandra L.
    Danilov, Alexey Valeryevich
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [44] A phase I dose-ranging study of bendamustine and rituximab in chronic lymphocytic leukemia patients with comorbidities
    Danilov, Alexey V.
    Lewis, Lionel D.
    Lansigan, Frederick
    Roudaia, Liya
    Findley, Darcie L.
    Jones, Susan Y.
    Highhouse, Brian
    Beaulieu, Bernard B.
    Brown, Jennifer R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (05) : 820 - 823
  • [45] Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study
    Michallet, Anne-Sophie
    Aktan, Melih
    Hiddemann, Wolfgang
    Ilhan, Osman
    Johansson, Peter
    Laribi, Kamel
    Meddeb, Balkis
    Moreno, Carol
    Raposo, Joao
    Schuh, Anna
    Unal, Ali
    Widenius, Tom
    Bernhardt, Alf
    Kellershohn, Kerstin
    Messeri, Dimitri
    Osborne, Stuart
    Leblond, Veronique
    HAEMATOLOGICA, 2018, 103 (04) : 698 - 706
  • [46] Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region
    Autore, Francesco
    Innocenti, Idanna
    Corrente, Francesco
    Del Principe, Maria Ilaria
    Rosati, Serena
    Falcucci, Paolo
    Fresa, Alberto
    Conte, Esmeralda
    Limongiello, Maria Assunta
    Renzi, Daniela
    De Padua, Laura
    Andriani, Alessandro
    Pisani, Francesco
    Cimino, Giuseppe
    Tafuri, Agostino
    Montanaro, Marco
    Mauro, Francesca Romana
    Del Poeta, Giovanni
    Laurenti, Luca
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [47] Efficacy and Safety Of Bendamustine In Combination With Rituximab For Elderly Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia. A Retrospective Multicenter Study
    Laurenti, Luca
    Vannata, Barbara
    Innocenti, Idanna
    Autore, Francesco
    Ghio, Francesco
    Cecconi, Nadia
    Pitini, Vincenzo
    Mondello, Patrizia
    Lanza Cariccio, Maria Rosa
    Gozzetti, Alessandro
    D'Arena, Giovanni
    Murru, Roberta
    Piccirillo, Nicola
    Leone, Giuseppe
    Sica, Simona
    BLOOD, 2013, 122 (21)
  • [48] Three-Year Follow-up of the Ascend Trial: Acalabrutinib Vs Rituximab Plus Idelalisib or Bendamustine in Relapsed/Refractory Chronic Lymphocytic Leukemia
    Jurczak, Wojciech
    Pluta, Andrzej
    Wach, Malgorzata
    Lysak, Daniel
    Kozak, Tomas
    Simkovic, Martin
    Kriachok, Iryna
    Illes, Arpad
    de la Serna, Javier
    Dolan, Sean
    Campbell, Philip
    Musuraca, Gerardo
    Jacob, Abraham
    Avery, Eric J.
    Lee, Jae Hoon
    Wang, Min Hui
    Yu, Ting
    Ghia, Paolo
    BLOOD, 2021, 138
  • [49] COST-EFFECTIVENESS OF RITUXIMAB IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN THE DUTCH SETTING
    Pompen, M.
    ten Hoor, G.
    Carr, E.
    Aultman, R.
    VALUE IN HEALTH, 2009, 12 (07) : A277 - A277
  • [50] Pentostatin and Rituximab Therapy for Previously Untreated Patients With B-Cell Chronic Lymphocytic Leukemia
    Kay, Neil E.
    Wu, Wenting
    Kabat, Brian
    LaPlant, Betsy
    Lin, Thomas S.
    Byrd, John C.
    Jelinek, Diane F.
    Greyer, Michael R.
    Zent, Clive S.
    Call, Timothy G.
    Shanafelt, Tait D.
    CANCER, 2010, 116 (09) : 2180 - 2187
12345